QIAGEN N.V. (QGEN) reporting calendar
QIAGEN N.V. files periodic reports with the SEC as QGEN on NYSE. Atlas tracks 25 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 20 Mar 2026
- Reports on record
- 25
Open QGEN market profile
Latest filing on SEC EDGAR ↗
Biological Products, (No Diagnostic Substances) reporting datesAll NYSE reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 20 Mar 2026 | 79 days | 0001015820-26-000018 |
| 20-F | 31 Dec 2024 | 31 Mar 2025 | 90 days | 0001015820-25-000027 |
| 20-F | 31 Dec 2023 | 11 Mar 2024 | 71 days | 0001015820-24-000022 |
| 20-F | 31 Dec 2022 | 13 Mar 2023 | 72 days | 0001015820-23-000012 |
| 20-F | 31 Dec 2021 | 14 Mar 2022 | 73 days | 0001015820-22-000017 |
| 20-F | 31 Dec 2020 | 5 Mar 2021 | 64 days | 0001015820-21-000018 |
| 20-F | 31 Dec 2019 | 2 Mar 2020 | 62 days | 0001015820-20-000015 |
| 20-F | 31 Dec 2018 | 6 Mar 2019 | 65 days | 0001015820-19-000009 |
| 20-F | 31 Dec 2017 | 6 Mar 2018 | 65 days | 0001015820-18-000010 |
| 20-F | 31 Dec 2016 | 6 Mar 2017 | 65 days | 0001015820-17-000011 |
| 20-F | 31 Dec 2015 | 29 Feb 2016 | 60 days | 0001015820-16-000054 |
| 20-F | 31 Dec 2014 | 2 Mar 2015 | 61 days | 0001015820-15-000006 |
| 20-F | 31 Dec 2013 | 3 Mar 2014 | 62 days | 0001015820-14-000008 |
| 20-F | 31 Dec 2012 | 4 Mar 2013 | 63 days | 0001015820-13-000005 |
| 20-F | 31 Dec 2011 | 27 Mar 2012 | 87 days | 0001015820-12-000005 |
| 20-F | 31 Dec 2010 | 21 Mar 2011 | 80 days | 0001193125-11-071539 |
| 20-F | 31 Dec 2009 | 17 Mar 2010 | 76 days | 0001193125-10-058832 |
| 20-F | 31 Dec 2008 | 25 Mar 2009 | 84 days | 0001193125-09-063088 |
| 20-F | 31 Dec 2007 | 20 Mar 2008 | 80 days | 0001193125-08-062046 |
| 20-F | 31 Dec 2006 | 2 Apr 2007 | 92 days | 0001193125-07-072260 |
| 20-F | 31 Dec 2005 | 3 Apr 2006 | 93 days | 0001193125-06-070924 |
| 20-F | 31 Dec 2004 | 19 Apr 2005 | 109 days | 0001193125-05-079427 |
| 20-F | 31 Dec 2003 | 26 Mar 2004 | 86 days | 0001193125-04-050173 |
| 20-F | 31 Dec 2002 | 31 Mar 2003 | 90 days | 0000927016-03-001493 |
| 20-F | 31 Dec 2001 | 2 Apr 2002 | 92 days | 0000927016-02-001861 |
Source: SEC EDGAR company submissions for CIK 0001015820. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.